Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/7/25 16:27 | 10/6/25 | VCYT | Health | Health | Medical Laboratories | Febbo Phillip G. | CA | O | Chief Sc | 1 | S | -301 | 36.02 | 0 | -8 | 92 | D | |||||||||||||||
10/3/25 16:16 | 10/1/25 | VCYT | Health | Health | Medical Laboratories | Leite John | CA | O | Chief Co | 1 | S | -89 | 35.00 | 0 | -3 | 89 | D | |||||||||||||||
10/3/25 16:16 | 10/1/25 | VCYT | Health | Health | Medical Laboratories | Epstein Robert S | CA | D | 1 | S.d | -753 | 35.08 | 0 | -21 | 62 | D | ||||||||||||||||
10/3/25 16:16 | 10/1/25 | VCYT | Health | Health | Medical Laboratories | McGuire Annie | CA | O | SVP,GC | 2 | S | -153 | 34.33 | 0 | -4 | 92 | D | |||||||||||||||
9/8/25 16:33 | 9/4/25 | VCYT | Health | Health | Medical Laboratories | Stapley Marc | CA | DO | CEO | 1 | S | -233 | 30.41 | 0 | -8 | 334 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |